Evidence map›Paper›PMID 39004861›Full record

ArticleZoological research2024

Genetically modified pigs with CD163 point mutation are resistant to HP-PRRSV infection.

Ying Liu, Lin Yang, Hong-Yong Xiang, Ming Niu, Jia-Cheng Deng, Xue-Yuan Li, Wen-Jie Hao, Hong-Sheng Ou-Yang, Tong-Yu Liu, Xiao-Chun Tang and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Zoological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Ying LiuState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Lin YangState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Hong-Yong XiangState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Ming NiuState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Jia-Cheng DengState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Xue-Yuan LiState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Wen-Jie HaoState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Hong-Sheng Ou-YangState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Tong-Yu LiuState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Xiao-Chun TangState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Da-Xin PangState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China.
Hong-Ming YuanState Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Animal Genome Editing Technology Innovation Center, College of Animal Sciences, Jilin University, Changchun, Jilin 130062, China. E-mail: yuanhongming@jlu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porcine reproductive and respiratory syndrome (PRRS) is a globally prevalent contagious disease caused by the positive-strand RNA PRRS virus (PRRSV), resulting in substantial economic losses in the swine industry. Modifying the CD163 SRCR5 domain, either through deletion or substitution, can eff1ectively confer resistance to PRRSV infection in pigs. However, large fragment modifications in pigs inevitably raise concerns about potential adverse effects on growth performance. Reducing the impact of genetic modifications on normal physiological functions is a promising direction for developing PRRSV-resistant pigs. In the current study, we identified a specific functional amino acid in CD163 that influences PRRSV proliferation. Viral infection experiments conducted on Marc145 and PK-15

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticPoint MutationPorcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusReceptors, Cell SurfaceAnimalsAnimals, Genetically ModifiedCD163 AntigenCell LineSwineAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenReceptors, Cell SurfaceCD163E529GPigsPoint mutationPRRSV

Identifiers

PMID39004861
PMCPMC11298667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.